Contract W81XWH12D0028
Aapharmasyn Llc · Department Of Defense · May 31, 2012
Aapharmasyn Llc was awarded a federal contract by Department Of Defense (Department Of The Army) on May 31, 2012 for an undisclosed amount of work in research and development in biotechnology. It was awarded under a small business set-aside. The contract has been modified 6 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on May 2, 2016.
Contract details
- PIID
- W81XWH12D0028
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Competed Under Sap
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Support- Professional: Other
- First action
- May 31, 2012
- Latest action
- May 2, 2016
Description
IGF::OT::IGF
Modification timeline
-
May 2, 2016Mod P00006$0
-
December 14, 2015Mod P00005$0
-
June 2, 2015Mod P00004$0
-
June 5, 2014Mod P00003NON-PERSONAL SERVICES$0
-
May 31, 2013Mod P00002NON-PERSONAL SERVICES$0
-
January 31, 2013Mod P00001NON-PERSONAL SERVICES$0
-
May 31, 2012Base awardNON-PERSONAL SERVICES$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $0 |
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $0 |
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $3.00M |
| Inbios International Inc | Department Of Defense | September 22, 2025 | $25.66M |
| Dynport Vaccine Company Llc | Department Of Defense | September 12, 2025 | $117.63M |
| Westat, Inc. | Department Of Defense | August 28, 2025 | $22.21M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81XWH12D0028?
Contract W81XWH12D0028 is a federal contract awarded to Aapharmasyn Llc by Department Of Defense on May 31, 2012 for an undisclosed amount of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 6 times since the base award.
Who won contract W81XWH12D0028?
Aapharmasyn Llc won contract W81XWH12D0028 from Department Of Defense.
How much is contract W81XWH12D0028 worth?
Contract W81XWH12D0028 has no obligated funds in the available record. It may be a pre-award placeholder or an indefinite-delivery vehicle awaiting task orders.